Efficacy and outcomes of antiplatelet therapy versus oral anticoagulants in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis

被引:4
作者
Goyal, Aman [1 ,2 ]
Abbasi, Fatima Qayyum [3 ]
Tariq, Muhammad Daoud [4 ]
Kanagala, Sai Gautham [7 ]
Changez, Mah I. Kan [5 ]
Safi, Darsh [1 ,2 ]
Basit, Jawad [6 ]
Sulaiman, Samia Aziz [8 ]
Marsool, Mohammed Dheyaa Marsool [9 ]
Daoud, Mohamed [10 ,12 ]
Sohail, Amir H. [11 ]
机构
[1] Seth GS Med Coll, Dept Internal Med, Mumbai, India
[2] King Edward Mem Hosp, Bombay, India
[3] Fed Med Coll, Islamabad, Pakistan
[4] Fdn Univ Med Coll, Islamabad, Pakistan
[5] Quetta Inst Med Sci, Dept Surg, Quetta, Pakistan
[6] Rawalpindi Med Univ, Dept Internal Med, Rawalpindi, Pakistan
[7] Metropolitan Hosp Ctr, Dept Internal Med, New York, NY USA
[8] Univ Jordan, Sch Med, Dept Internal Med, Amman, Jordan
[9] Univ Baghdad, Al Kindy Coll Med, Dept Internal Med, Baghdad, Iraq
[10] Bogomolets Natl Med Univ, Dept Internal Med, Kiev, Ukraine
[11] Univ New Mexico Hlth Sci, Dept Surg, Albuqurque, NM USA
[12] Bogomolets Natl Med Univ, Peremohy Ave 34, UA-02000 Kiev, Ukraine
关键词
antiplatelet therapy; cardiology; direct oral anticoagulants; TAVR; thrombotic complications; vitamin k antagonists; IMPLANTATION; DEFINITIONS;
D O I
10.1097/MS9.0000000000001908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Recent guidelines suggest that antiplatelet therapy (APT) is the standard of care in the absence of long-term oral anticoagulation (OAC) indications in patients post-transcatheter aortic valve replacement (TAVR). The superiority of one method over the other remains controversial.Materials and methods:Several databases, including MEDLINE, Google Scholar, and EMBASE, were electronically searched. The primary endpoint was the all-cause mortality (ACM) rate. Secondary endpoints included cardiovascular death, myocardial infarction (MI), stroke/TIA, haemorrhagic stroke, bleeding events, systemic embolism, and valve thrombosis in post-TAVR patients receiving APT and oral anticoagulants (OACs). Forest plots were generated using Review Manager version 5.4, with a p value less than 0.05 indicating statistical significance. Subgroup analysis was performed to explore potential sources of heterogeneity.Results:Twelve studies were selected. No significant differences were observed in APT and OAC group for ACM [risk ratio (RR): 0.67; 95% CI:0.45-1.01; P=0.05], cardiovascular death [RR:0.91; 95% CI:0.73-1.14; P=0.42], MI [RR:1.69; 95% CI:0.43-6.72; P=0.46], Stroke/TIA [RR:0.79; 95% CI:0.58-1.06; P=0.12], ischaemic stroke [RR:0.83; 95% CI:0.50-1.37; P=0.47], haemorrhagic stroke [RR:1.08; 95% CI: 0.23-5.15; P=0.92], major bleeding [RR:0.79; 95% CI:0.51-1.21; P=0.28], minor bleeding [RR:1.09; 95% CI: 0.80-1.47; P=0.58], life-threatening bleeding [RR:0.85; 95% CI:0.55-1.30; P=0.45], any bleeding [RR:0.98; 95% CI:0.83-1.15; P=0.78], and systemic embolism [RR:0.87; 95% CI:0.44-1.70; P=0.68]. The risk of valve thrombosis was higher in patients receiving APT than in those receiving OAC [RR:2.61; 95% CI:1.56-4.36; P =0.0002].Conclusions:Although the risk of valve thrombosis increased in patients receiving APT, the risk of other endpoints was comparable between the two groups.
引用
收藏
页码:2911 / 2925
页数:15
相关论文
共 30 条
[1]   2017 ESC/EACTS Guidelines for the management of valvular heart disease [J].
Baumgartner, Helmut ;
Falk, Volkmar ;
Bax, Jeroen J. ;
De Bonis, Michele ;
Hamm, Christian ;
Holm, Johan ;
Iung, Bernard ;
Lancellotti, Patrizio ;
Lansac, Emmanuel ;
Munoz, Daniel Rodriguez ;
Rosenhek, Raphael ;
Sjogren, Johan ;
Mas, Pilar Tornos ;
Vahanian, Alec ;
Walther, Thomas ;
Windecker, Stephan ;
Zamorano, Jose Luis .
KARDIOLOGIA POLSKA, 2018, 76 (01) :1-62
[2]   Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial [J].
Collet, Jean-Philippe ;
Van Belle, Eric ;
Thiele, Holger ;
Berti, Sergio ;
Lhermusier, Thibault ;
Manigold, Thibault ;
Neumann, Franz-Josef ;
Gilard, Martine ;
Attias, David ;
Beygui, Farzin ;
Cequier, Angel ;
Alfonso, Fernando ;
Aubry, Pierre ;
Baronnet, Flore ;
Ederhy, Stephane ;
El Kasty, Mohamad ;
Kerneis, Mathieu ;
Barthelemy, Olivier ;
Lefevre, Thierry ;
Leprince, Pascal ;
Redheuil, Alban ;
Henry, Patrick ;
Portal, Jean-Jacques ;
Vicaut, Eric ;
Montalescot, Gilles .
EUROPEAN HEART JOURNAL, 2022, 43 (29) :2783-2797
[3]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[4]   A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement [J].
Dangas, George D. ;
Tijssen, Jan G. P. ;
Woehrle, Jochen ;
Sondergaard, Lars ;
Gilard, Martine ;
Moellmann, Helge ;
Makkar, Raj R. ;
Herrmann, Howard C. ;
Giustino, Gennaro ;
Baldus, Stephan ;
De Backer, Ole ;
Guimaraes, Ana H. C. ;
Gullestad, Lars ;
Kini, Annapoorna ;
von Lewinski, Dirk ;
Mack, Michael ;
Moreno, Raul ;
Schaefer, Ulrich ;
Seeger, Julia ;
Tchetche, Didier ;
Thomitzek, Karen ;
Valgimigli, Marco ;
Vranckx, Pascal ;
Welsh, Robert C. ;
Wildgoose, Peter ;
Volkl, Albert A. ;
Zazula, Ana ;
van Amsterdam, Ronald G. M. ;
Mehran, Roxana ;
Windecker, Stephan .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02) :120-129
[5]   Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement [J].
De Backer, Ole ;
Dangas, George D. ;
Jilaihawi, Hasan ;
Leipsic, Jonathon A. ;
Terkelsen, Christian J. ;
Makkar, Raj ;
Kini, Annapoorna S. ;
Veien, Karsten T. ;
Abdel-Wahab, Mohamed ;
Kim, Won-Keun ;
Balan, Prakash ;
Van Mieghem, Nicolas ;
Mathiassen, Ole N. ;
Jeger, Raban V. ;
Arnold, Martin ;
Mehran, Roxana ;
Guimaraes, Ana H. C. ;
Norgaard, Bjarne L. ;
Kofoed, Klaus F. ;
Blanke, Philipp ;
Windecker, Stephan ;
Sondergaard, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02) :130-139
[6]   TAVR Patients Requiring Anticoagulation Direct Oral Anticoagulant or Vitamin K Antagonist? [J].
Didier, Romain ;
Lhermusier, Thibault ;
Auffret, Vincent ;
Eltchaninoff, Helene ;
Le Breton, Herve ;
Cayla, Guillaume ;
Commeau, Philippe ;
Collet, Jean Philippe ;
Cuisset, Thomas ;
Dumonteil, Nicolas ;
Verhoye, Jean Philippe ;
Beurtheret, Sylvain ;
Lefevre, Thierry ;
Teiger, Emmanuel ;
Carrie, Didier ;
Himbert, Dominique ;
Albat, Bernard ;
Cribier, Alain ;
Sudre, Arnaud ;
Blanchard, Didier ;
Bar, Olivier ;
Rioufol, Gilles ;
Collet, Frederic ;
Houel, Remi ;
Labrousse, Louis ;
Meneveau, Nicolas ;
Ghostine, Said ;
Manigold, Thibaut ;
Guyon, Philippe ;
Delepine, Stephane ;
Favereau, Xavier ;
Souteyrand, Geraud ;
Ohlmann, Patrick ;
Doisy, Vincent ;
Beygui, Farzin ;
Gommeaux, Antoine ;
Claudel, Jean-Philippe ;
Bourlon, Francois ;
Bertrand, Bernard ;
Iung, Bernard ;
Gilard, Martine .
JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (15) :1704-1713
[7]   Treating Symptomatic Aortic Stenosis With Transcatheter Aortic Valve Replacement: Is There Time to Wait? [J].
Faridi, Kamil F. ;
Yeh, Robert W. ;
Poulin, Marie-France .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (01)
[8]   The "Big Five" Complications After Transcatheter Aortic Valve Replacement Do We Still Have to Be Afraid of Them? [J].
Grube, Eberhard ;
Sinning, Jan-Malte .
JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) :370-372
[9]   Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience [J].
Gurevich, Sergey ;
Oestreich, Brett ;
Kelly, Rosemary F. ;
Mbai, Mackenzie ;
Bertog, Stefan ;
Yannopoulos, Demetris ;
Garcia, Santiago .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (05) :621-625
[10]   Real-World Anticoagulatory Treatment After Transcatheter Aortic Valve Replacement: A Retrospective, Observational Study on 4,800 Patients [J].
Hohmann, Christopher ;
Ludwig, Marion ;
Walker, Jochen ;
Wienemann, Hendrik ;
Baldus, Stephan ;
Pfister, Roman .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8